Hepatitis C News

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

According to HHS, many of the more than 3.2 million people in the United States with hepatitis B or C are not aware of their infection, raising their risk for severe complications or death and risking further spread of the viruses.

Results from a systematic review and meta-analysis demonstrated greater risk for hepatitis C virus and HIV infection among women and younger people who inject drugs, according to data reported in The Lancet Gastroenterology & Hepatology.

Hepatitis C virus among the U.S. obstetric population rose nearly 10-fold over 20 years, which might reflect an increase in screening or prevalence, according to researchers.

A call back system in Taiwan helped retrieve patients with chronic hepatitis C virus infection who were lost to follow-up and has the potential to boost micro-elimination efforts, according to research in BMC Gastroenterology.

Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.

Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported.

WASHINGTON — In this video, Norah Terrault, MD, MPG, FAASLD, chief of gastroenterology and liver diseases at the University of Southern California Keck School of Medicine, discusses a national strategy to eliminate hepatitis C virus.

WASHINGTON — A leading expert in hepatology called for fellow specialists to embrace a role of education, advocacy and support as part of a proposed national hepatitis C virus elimination program presented during The Liver Meeting.